Q98409206

Summary

Q98409206 is a report^[1].

Key Facts

• Q98409206's instance of is recorded as report^[2].
• Q98409206's part of the series is recorded as reports of the 2012/13 legislative session of the Riksdag^[3].
• Q98409206's language of work or name is recorded as Swedish^[4].
• Q98409206 was released on +2013-01-18T00:00:00Z^[5].
• Q98409206's main subject is medication^[6].
• Q98409206's work available at URL is recorded as http://data.riksdagen.se/dokument/H001SoU7^[7].
• Q98409206's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H001SoU7^[8].
• Q98409206's work available at URL is recorded as http://data.riksdagen.se/fil/5C62D463-7A2B-46B1-B964-6AAD4C0661B5^[9].
• Q98409206's applies to jurisdiction is recorded as Sweden^[10].
• Q98409206's legal citation of this text is recorded as bet. 2012/13:SoU7^[11].
• Q98409206's title is recorded as Genomförande av ändringsdirektiv 2011/62/EU Skydd mot förfalskade läkemedel i den lagliga försörjningskedjan^[12].
• Q98409206's has immediate cause is recorded as Q98126976^[13].
• Q98409206's has immediate cause is recorded as Q97785205^[14].
• Q98409206's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98409206's copyright status is recorded as public domain^[16].
• Q98409206's legislative committee is recorded as Committee on Health and Welfare^[17].

Body

Definition and Type

Q98409206's instance of is recorded as report^[2].